Showing all 2 results

Active Filters: Clear Filters

What is Soma?

SOMA is for the alleviation of pain related to acute, severe musculoskeletal conditions in adults.

Patients should use SOMA for brief periods (up to a little while) because sufficient proof of viability for increasingly drawn-out use has not up and because intense, severe musculoskeletal conditions are by and large of brief length.

Dosage of Soma

The suggested portion of SOMA is 250 mg to 350 mg three times each day and at sleep time. The suggested most extreme span of SOMA use is up to half a month.

Accessible Forms and qualities 

  • Soma 250 mg Tablets: round, raised, white tablets, imprint with SOMA 250
  • Soma 350 mg Tablets: round, raised, white pills, imprint with SOMA 350

Precautionary measures 

Sedation 

SOMA has narcotic properties (in the low back torment preliminaries, 13% to 17% of patients who got SOMA experienced sedation contrasted with 6% of patients who got fake treatment) [SEE ADVERSE REACTIONS (6.1)] and may hinder the psychological as well as physical capacities required for the exhibition of possibly perilous undertakings, for example, driving an engine vehicle or working apparatus. There have been post-showcasing reports of engine vehicle mishaps related to the use of SOMA.

Since the calming impacts of SOMA and different CNS depressants (e.g., alcohol, benzodiazepines, narcotics, tricyclic antidepressants) might be added substance, practice proper alert with patients who take more than one of these CNS depressants all the while.

  • Abuse, Dependence, and Withdrawal 

Carisoprodol, the dynamic fixing in SOMA, has been liable to mishandle, reliance, and withdrawal, abuse, and criminal redirection. Maltreatment of SOMA represents a danger of overdosage, which may prompt demise, CNS and respiratory melancholy, hypotension, seizures, and different issue.

To decrease the danger of SOMA misuse, evaluate the threat of maltreatment preceding recommending. Subsequent, as far as possible, the length of treatment to three weeks for the alleviation of intense musculoskeletal inconvenience, keep cautious solution records, screen for indications of misuse and overdose, and instruct patients and their families about maltreatment and on appropriate capacity and removal.

  • Seizures 

There have been post-showcasing reports of seizures in patients who got SOMA. A large portion of these cases have happened in the setting of numerous medication overdoses (counting medications of misuse, unlawful drugs, and alcohol)

Side effects of Soma:

The most common Soma side effects include:

  • Dizziness
  • Drowsiness
  • Headache

However, severe side effects of Soma are less likely to occur; they can happen in some individuals with health conditions or people who are taking the medication at a higher dose or for more extended periods. Some severe adverse reactions of Soma include:

  • Cardiovascular: Tachycardia, postural hypotension, and facial flushing.
  • Focal Nervous System: Drowsiness, wooziness, vertigo, ataxia, tremor, tumult, fractiousness, migraine, burdensome responses, syncope, sleep deprivation, and seizures
  • Gastrointestinal: Nausea, regurgitating, and epigastric distress.
  • Hematologic: Leukopenia, pancytopenia

Drug Interactions

  • CNS Depressants 

The calming impacts of SOMA and different CNS depressants (e.g., alcohol, benzodiazepines, narcotics, tricyclic antidepressants) might be added substance. Along these lines, alert ought to be practiced with patients who take more than one of these CNS depressants all the while. Corresponding use of SOMA and meprobamate, a metabolite of SOMA, isn’t suggested.

  • CYP2C19 Inhibitors and Inducers 

Carisoprodol is used in the liver by CYP2C19 to shape meprobamate [SEE CLINICAL PHARMACOLOGY (12.3) ]. Co-organization of CYP2C19 inhibitors, for example, omeprazole or fluvoxamine, with SOMA could bring about expanded presentation of carisoprodol and diminished introduction of meprobamate. Co-organization of CYP2C19 inducers, for example, rifampin or St. John’s Wort, with SOMA, could bring about the reduced introduction of carisoprodol and expanded presentation of meprobamate. Low portion headache medicine likewise demonstrated an enlistment impact on CYP2C19. The full pharmacological effect of these potential modifications of exposures regarding either adequacy or wellbeing of SOMA is obscure.

Controlled substance 

SOMA has carisoprodol, a Schedule IV controlled substance. Carisoprodol has been liable to mishandle, abuse, and criminal redirection for nontherapeutic use.

Soma abuse 

Maltreatment of carisoprodol represents a danger of overdosage, which may prompt demise, CNS and respiratory sadness, hypotension, seizures, and different issue. Patients at risk of SOMA misuse may incorporate those with delayed use of carisoprodol, with a background marked by medicating abuse, or the individuals who use SOMA in a mix with other mishandled drugs.

Physician endorsed medicate misuse is the deliberate non-restorative use of a medication, even once, for its compensating mental impacts. Chronic drug use, which creates after rehashed medicate misuse, is portrayed by a powerful urge to take a medication regardless of unsafe results, trouble in controlling its use, giving a higher need to sedate use than to commitments, expanded resistance, and once in awhile physical withdrawal. Medication misuse and illicit drug use are discrete and particular from physical reliance and resilience (for instance, misuse or fixation may not accompany resistance or physical dependence).

Soma dependence 

Resilience is the point at which a patient’s response to particular measurements and fixation is logically decreased without malady movement, requiring an expansion in the dose to keep up the equivalent. Physical reliance causes withdrawal side effects after a sudden end or a critical portion decrease of a medication. Both resilience and physical dependence relate to the delayed use of SOMA. Announced withdrawal side effects with SOMA incorporate a sleeping disorder, spewing, stomach cramps, cerebral pain, tremors, muscle jerking, uneasiness, ataxia, mind flights, and psychosis. Patients are taking huge portions of SOMA or those taking the medication for a delayed time, not suddenly to stop SOMA.